Research Summary
Artificial blood is a substance that mimics the oxygen-carrying properties of red blood cells. It is designed to replace or supplement the use of donated blood in transfusions, and can be used in emergency situations where donated blood is unavailable or in limited supply. Artificial blood is typically made using hemoglobin, the protein in red blood cells that carries oxygen, and can be either a standalone product or combined with other materials to form a blood substitute. While artificial blood research and development has been ongoing for several decades, no commercially available product has yet been widely adopted for human use.
According to DIResearch's in-depth investigation and research, the global Artificial Blood market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Artificial Blood include Dextro-Sang Corporation, BioPure Corporation, Sangart, Northfield Laboratories, Baxter International, Dentritech, FluorO2 Therapeutics, Nuvox Pharma, Alpha Therapeutic Corporation, HemoBioTech etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Artificial Blood. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Artificial Blood market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Artificial Blood market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Artificial Blood industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy. ? ?
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Artificial Blood Include:
Dextro-Sang Corporation
BioPure Corporation
Sangart
Northfield Laboratories
Baxter International
Dentritech
FluorO2 Therapeutics
Nuvox Pharma
Alpha Therapeutic Corporation
HemoBioTech
Artificial Blood Product Segment Include:
Human Blood
Synthetic Blood
Animal Blood
Artificial Blood Product Application Include:
Hemoglobin-Based Oxygen Carriers (HBOCs)
Perflurocarbon Emulsions (PFCEs)
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Artificial Blood Industry PESTEL Analysis
Chapter 3: Global Artificial Blood Industry Porter's Five Forces Analysis
Chapter 4: Global Artificial Blood Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Artificial Blood Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Artificial Blood Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Artificial Blood Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Artificial Blood Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Artificial Blood Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Artificial Blood Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Artificial Blood Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Artificial Blood Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Artificial Blood Market Overview 1.1 Product Definition and Statistical Scope 1.2 Artificial Blood Product by Type 1.2.1 Global Artificial Blood Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Human Blood 1.2.3 Synthetic Blood 1.2.4 Animal Blood 1.3 Artificial Blood Product by Application 1.3.1 Global Artificial Blood Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Hemoglobin-Based Oxygen Carriers (HBOCs) 1.3.3 Perflurocarbon Emulsions (PFCEs) 1.4 Global Artificial Blood Market Revenue and Sales Analysis 1.4.1 Global Artificial Blood Market Size Analysis (2019-2030) 1.4.2 Global Artificial Blood Market Sales Analysis (2019-2030) 1.4.3 Global Artificial Blood Market Sales Price Trend Analysis (2019-2030) 1.5 Artificial Blood Market Development Status and Trends 1.5.1 Artificial Blood Industry Development Status Analysis 1.5.2 Artificial Blood Industry Development Trends Analysis 2 Artificial Blood Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Artificial Blood Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Artificial Blood Market Analysis by Regions 4.1 Artificial Blood Overall Market: 2023 VS 2024 VS 2030 4.2 Global Artificial Blood Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Artificial Blood Revenue and Market Share by Region (2019-2024) 4.2.2 Global Artificial Blood Revenue Forecast by Region (2025-2030) 4.3 Global Artificial Blood Sales and Forecast Analysis (2019-2030) 4.3.1 Global Artificial Blood Sales and Market Share by Region (2019-2024) 4.3.2 Global Artificial Blood Sales Forecast by Region (2025-2030) 4.4 Global Artificial Blood Sales Price Trend Analysis (2019-2030) 5 Global Artificial Blood Market Size by Type and Application 5.1 Global Artificial Blood Market Size by Type 5.1.1 Global Artificial Blood Revenue and Forecast Analysis by Type (2019-2030) 5.1.2 Global Artificial Blood Sales and Forecast Analysis by Type (2019-2030) 5.2 Global Artificial Blood Market Size by Application 5.2.1 Global Artificial Blood Revenue and Forecast Analysis by Application (2019-2030) 5.2.2 Global Artificial Blood Sales and Forecast Analysis by Application (2019-2030) 6 North America 6.1 North America Artificial Blood Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Artificial Blood Market Size by Type 6.3.1 North America Artificial Blood Sales by Type (2019-2030) 6.3.2 North America Artificial Blood Revenue by Type (2019-2030) 6.4 North America Artificial Blood Market Size by Application 6.4.1 North America Artificial Blood Sales by Application (2019-2030) 6.4.2 North America Artificial Blood Revenue by Application (2019-2030) 6.5 North America Artificial Blood Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Artificial Blood Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Artificial Blood Market Size by Type 7.3.1 Europe Artificial Blood Sales by Type (2019-2030) 7.3.2 Europe Artificial Blood Revenue by Type (2019-2030) 7.4 Europe Artificial Blood Market Size by Application 7.4.1 Europe Artificial Blood Sales by Application (2019-2030) 7.4.2 ? Europe Artificial Blood Revenue by Application (2019-2030) 7.5 Europe Artificial Blood Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Artificial Blood Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Artificial Blood Market Size by Type 8.3.1 China Artificial Blood Sales by Type (2019-2030) 8.3.2 China Artificial Blood Revenue by Type (2019-2030) 8.4 China Artificial Blood Market Size by Application 8.4.1 China Artificial Blood Sales by Application (2019-2030) 8.4.2 China Artificial Blood Revenue by Application (2019-2030) 9 APAC (excl. China) 9.1 APAC (excl. China) Artificial Blood Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Artificial Blood Market Size by Type 9.3.1 APAC (excl. China) Artificial Blood Sales by Type (2019-2030) 9.3.2 APAC (excl. China) Artificial Blood Revenue by Type (2019-2030) 9.4 APAC (excl. China) Artificial Blood Market Size by Application 9.4.1 APAC (excl. China) Artificial Blood Sales by Application (2019-2030) 9.4.2 APAC (excl. China) Artificial Blood Revenue by Application (2019-2030) 9.5 APAC (excl. China) Artificial Blood Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Artificial Blood Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Artificial Blood Market Size by Type 10.3.1 Latin America Artificial Blood Sales by Type (2019-2030) 10.3.2 Latin America Artificial Blood Revenue by Type (2019-2030) 10.4 Latin America Artificial Blood Market Size by Application 10.4.1 Latin America Artificial Blood Sales by Application (2019-2030) 10.4.2 Latin America Artificial Blood Revenue by Application (2019-2030) 10.5 Latin America Artificial Blood Market Size by Country 10.5.1 Mexico 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Artificial Blood Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Artificial Blood Market Size by Type 11.3.1 Middle East & Africa Artificial Blood Sales by Type (2019-2030) 11.3.2 Middle East & Africa Artificial Blood Revenue by Type (2019-2030) 11.4 Middle East & Africa Artificial Blood Market Size by Application 11.4.1 Middle East & Africa Artificial Blood Sales by Application (2019-2030) 11.4.2 Middle East & Africa Artificial Blood Revenue by Application (2019-2030) 11.5 Middle East & Africa Artificial Blood Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Competition by Manufacturers 12.1 Global Artificial Blood Market Sales, Revenue and Price by Key Manufacturers (2020-2024) 12.1.1 Global Artificial Blood Market Sales by Key Manufacturers (2020-2024) 12.1.2 Global Artificial Blood Market Revenue by Key Manufacturers (2020-2024) 12.1.3 Global Artificial Blood Average Sales Price by Manufacturers (2020-2024) 12.2 Artificial Blood Competitive Landscape Analysis and Market Dynamic 12.2.1 Artificial Blood Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Dextro-Sang Corporation 13.1.1 Dextro-Sang Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Dextro-Sang Corporation Artificial Blood Product Portfolio 13.1.3 Dextro-Sang Corporation Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.2 BioPure Corporation 13.2.1 BioPure Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 BioPure Corporation Artificial Blood Product Portfolio 13.2.3 BioPure Corporation Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.3 Sangart 13.3.1 Sangart Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Sangart Artificial Blood Product Portfolio 13.3.3 Sangart Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.4 Northfield Laboratories 13.4.1 Northfield Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Northfield Laboratories Artificial Blood Product Portfolio 13.4.3 Northfield Laboratories Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.5 Baxter International 13.5.1 Baxter International Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Baxter International Artificial Blood Product Portfolio 13.5.3 Baxter International Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.6 Dentritech 13.6.1 Dentritech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Dentritech Artificial Blood Product Portfolio 13.6.3 Dentritech Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.7 FluorO2 Therapeutics 13.7.1 FluorO2 Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 FluorO2 Therapeutics Artificial Blood Product Portfolio 13.7.3 FluorO2 Therapeutics Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.8 Nuvox Pharma 13.8.1 Nuvox Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Nuvox Pharma Artificial Blood Product Portfolio 13.8.3 Nuvox Pharma Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.9 Alpha Therapeutic Corporation 13.9.1 Alpha Therapeutic Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Alpha Therapeutic Corporation Artificial Blood Product Portfolio 13.9.3 Alpha Therapeutic Corporation Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.10 HemoBioTech 13.10.1 HemoBioTech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 HemoBioTech Artificial Blood Product Portfolio 13.10.3 HemoBioTech Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Artificial Blood Industry Chain Analysis 14.2 Artificial Blood Industry Upstream Supply Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Artificial Blood Typical Downstream Customers 14.4 Artificial Blood Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Intrauterine Devices Market By Product Type (Hormonal Intrauterine Device and Copper Intrauterine Device), By Material (Plastic, Copper and Hormonal (Levonorgestrel)), By Age Group (15-24 years, 25-34 years, 35-44 years and Above 44 years), By End-user (Hospital, Gynecology Clinics, Community Health Care Centers and Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
- Arterial Thrombectomy Devices Market By Device Type (Aspiration Thrombectomy Devices, Mechanical Thrombectomy Devices, Rheolytic Thrombectomy Devices, Ultrasound-Assisted Thrombectomy Devices, Laser-Based Thrombectomy Devices, Others), By Application (Peripheral Arterial Disease (PAD), Coronary Artery Disease (CAD), Ischemic Stroke, Renal Artery Thrombosis, Acute limb Ischemia, Others), By End-user (Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs), Academic and Research Institutions), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
- Global Operating Room Infection Control Consumable Competitive Landscape Professional Research Report 2024
- Global Oral Fluid Drug Test System Competitive Landscape Professional Research Report 2024
- Global Orthopaedics Competitive Landscape Professional Research Report 2024
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support